Drug companies step up Ebola vaccine race

Reuters

Email Print

RELATED NEWS

 
As the WHO opens its third emergency meeting on Ebola, Johnson and Johnson says it's speeding up work on an experimental vaccine against the disease - putting pressure on its main rivals in the vaccine race, GSK and NewLink Genetics, to do the same.
 
 
 

More Health News